Kimberly-Clark announced plans to acquire Kenvue, the maker of Tylenol and Listerine, in a cash and stock deal valued at approximately $48.7 billion. The transaction marks one of the largest corporate takeovers of the year and will unite some of the world’s most recognized household and healthcare brands under a single company. Following the merger, shareholders of Kimberly-Clark will hold about 54 percent of the combined entity, while Kenvue investors will own the remaining 46 pe